文献速递胃肠外科围术期管理与 ERAS

控制营养状况(CONUT)评分作为胃癌根治性胃切除术后预后免疫营养生物标志物:倾向性评分匹配分析

Controlling Nutritional Status (CONUT) as a prognostic immunonutritional biomarker for gastric cancer after curative gastrectomy: a propensity score-matched analysis.
PubMed 文献 · Surg Endosc · 2019-03-05

该回顾性研究纳入368例接受根治性腹腔镜辅助胃切除术的胃癌患者,评估CONUT评分的预后价值,并按血清CEA水平分层分析。倾向性评分匹配控制肿瘤深度、淋巴结转移和pTNM分期后,发现CONUT评分是全组及CEA正常或升高亚组总生存的独立预后因素。

要点

  • CONUT评分高(≥3)与胃癌根治术后总生存差独立相关。
  • CONUT评分联合CEA水平可同时反映宿主与肿瘤因素,优化预后评估。
  • 在CEA正常患者中,CONUT评分仍是独立预后因素。

核心结论

  • CONUT评分是胃癌根治性胃切除术后总生存的独立预后因素。
  • 联合CEA水平与CONUT评分有助于评估胃癌患者预后。

研究设计与样本

  • 回顾性队列研究,纳入368例连续接受根治性腹腔镜辅助胃切除术的胃癌患者。
  • 采用倾向性评分匹配控制肿瘤深度、淋巴结转移和pTNM分期等混杂因素。

主要发现

  • 全组患者中,肿瘤分期(HR 2.231,p=0.001)、CONUT评分(HR 2.254,p=0.001)和血清CEA水平(HR 1.821,p=0.025)是总生存的独立预测因素。
  • 术前血清CEA正常组中,肿瘤分期(HR 2.350,p=0.007)和CONUT评分(HR 1.990,p=0.028)是总生存的独立预后因素。
  • 血清CEA高水平组中,肿瘤大小(HR 2.930,p=0.015)和CONUT评分(HR 3.707,p=0.004)是总生存的独立预后因素。

临床怎么用

  • 可利用CONUT评分联合CEA水平对胃癌根治术后患者进行预后分层。

局限性

  • 回顾性研究设计,样本量有限,结论需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In clinical practice, it is not unusual to treat oncologic patients whose tumor markers are within normal range, even with advanced cancer. The Controlling Nutritional Status (CONUT) score could provide a useful nutritional and immunological prognostic biomarker for cancer patients. In this study, we assessed the prognostic value of the CONUT score for patients with gastric cancer, including a subgroup analysis with stratification based on serum carcinoembryonic antigen (CEA) level. METHODS: We retrospectively reviewed the medical records of 368 consecutive patients who underwent curative laparoscopy-assisted gastrectomy. The prognostic value of the CONUT score was compared between patients with a low (≤ 2) and high (≥ 3) score, with propensity score matching (PSM) used to control for biasing covariates (Depth of tumor, Lymph node metastasis, pathological TNM (pTNM) stage). RESULTS: Overall survival (OS) among all patients was independently predicted by the tumor stage (hazard ratio (HR): 2.231, p = 0.001), the CONUT score (HR: 2.254, p = 0.001), and serum CEA level (HR: 1.821, p = 0.025). Among patients with a normal preoperative serum CEA level, tumor stage (HR: 2.350, p = 0.007), and the CONUT score (HR: 1.990, p = 0.028) were independent prognostic factors of OS. In the high serum CEA level group, tumor size (HR: 2.930, p = 0.015) and the CONUT score (HR: 3.707, p = 0.004) were independent prognostic factors of OS. CONCLUSIONS: It is advantageous to use both CEA level and the CONUT score to assess the prognosis of patients with gastric cancer, which reflect both tumor-related factors and host-related factors, respectively.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hirahara N, Tajima Y, Fujii Y, et al. Controlling Nutritional Status (CONUT) as a prognostic immunonutritional biomarker for gastric cancer after curative gastrectomy: a propensity score-matched analysis. Surg Endosc. 2019. PMID: 30838449. doi:10.1007/s00464-019-06723-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。